Free Trial

Jazz Pharmaceuticals (JAZZ) SEC Filings & 10K Form

Jazz Pharmaceuticals logo
$119.24 +2.42 (+2.07%)
(As of 11/20/2024 ET)

Recent Jazz Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/13/2024
4:44 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:44 AM
BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
4:55 PM
Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
6:32 AM
Jazz Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
3:06 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:00 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
2:19 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
Form SC 13G/A
10/16/2024
3:13 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
10:38 AM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:50 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
1:27 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
5:39 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:39 PM
Jazz Pharmaceuticals (Issuer)
McSharry Heather Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:40 PM
Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:40 PM
Jazz Pharmaceuticals (Issuer)
ORiordan Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:41 PM
Jazz Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:42 PM
Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:42 PM
Jazz Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:45 PM
ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:48 PM
Hamill Laura (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:50 PM
Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:52 PM
Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:53 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
8:57 PM
Jazz Pharmaceuticals (Subject)
Winningham Rick E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:29 PM
Jazz Pharmaceuticals (Subject)
McSharry Heather Ann (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:35 PM
Jazz Pharmaceuticals (Subject)
O'Keefe Kenneth W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:42 PM
Jazz Pharmaceuticals (Subject)
ORiordan Anne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:49 PM
Jazz Pharmaceuticals (Subject)
RIEDEL NORBERT G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:55 PM
Jazz Pharmaceuticals (Subject)
Smith Mark Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:19 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
6:33 AM
Jazz Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
3:06 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
7:11 PM
Hamill Laura (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/22/2024
3:46 PM
Jazz Pharmaceuticals (Filer)
Form DEFA14A
07/22/2024
6:57 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
7:15 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:44 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
4:31 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
6:38 AM
Jazz Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/09/2024
3:39 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 
03/08/2024
5:07 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:49 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:53 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:44 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:47 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:48 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:09 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:54 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:58 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:28 PM
Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:32 PM
Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:34 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:44 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:47 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:50 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:52 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:11 PM
Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/05/2024
6:14 PM
Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/01/2024
2:11 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
3:06 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
6:45 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
6:46 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:29 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/25/2024
4:01 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
Form SC 13G/A
01/19/2024
5:19 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:21 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:23 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:25 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:28 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:33 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:45 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
6:45 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
3:39 PM
Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
3:31 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:JAZZ) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners